New drug candidate B-OT tested in humans for first time
NCT ID NCT07450833
First seen Mar 17, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This early-stage study tested a new drug called Benfo-Oxythiamine (B-OT) in 48 healthy male volunteers to see if it is safe and how the body processes it. Researchers are exploring B-OT as a potential treatment for infectious diseases and cancer. Participants took the drug as capsules and were closely monitored for side effects, with blood and urine samples collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Diagnostics and Consultation Center (DCC) Convex EOOD
Sofia, Bulgaria
Conditions
Explore the condition pages connected to this study.